Deepa Prasad, Director at Design Therapeutics, Inc. (DSGN), sold 3,806 shares at $6.27 ($24K) on 2024-12-18, disclosed to the SEC on 2024-12-19.
Open-market sale of $24k DSGN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.